What Companies Does Vivek Ramaswamy Own?

Vivek Ramaswamy is an American entrepreneur and presidential candidate who has built a diverse portfolio of businesses under his ownership. With a strong presence in the biotech and financial industries, Ramaswamy has strategically acquired and invested in various companies, showcasing his business acumen and success in these sectors.

Key Takeaways:

• Vivek Ramaswamy owns multiple companies in various industries.
• His investments and acquisitions have helped him build a diverse portfolio.
• Ramaswamy’s key company is Roivant Sciences, a successful biotechnology firm.
• He also co-founded Strive Asset Management, an investment firm focused on delivering excellent products and services.
• His success in both biotech and finance industries highlights his entrepreneurial skills.

The Success of Roivant Sciences

One of the key companies owned by Vivek Ramaswamy is Roivant Sciences. Founded in 2014, Roivant Sciences is a biotechnology firm that focuses on acquiring patents for drugs that have not yet been successfully developed. The company has created multiple subsidiaries, including Dermavant, Urovant, Sinovant, and Cytovant, each specializing in different areas of pharmaceutical development.

Ramaswamy’s leadership has led to the success of Roivant Sciences, with the company going public in 2021 and experiencing significant growth in its stock value. His strategic investments and acquisitions within the biotech industry have helped him build a strong and diverse portfolio of companies.

Roivant Sciences Subsidiaries

Subsidiary	Area of Focus
Dermavant	Dermatology
Urovant	Urology
Sinovant	Chinese biopharma
Cytovant	Cell and gene therapies

Roivant Sciences’ subsidiaries allow the company to focus on specific therapeutic areas, maximizing its expertise and potential for success. This strategic approach has positioned Roivant Sciences as a significant player in the biotech industry, with a strong pipeline of drugs and therapies under development.

Ramaswamy’s commitment to innovation and growth has propelled Roivant Sciences to the forefront of the biotech sector, solidifying his reputation as a successful entrepreneur and investor.

The Rise of Strive Asset Management

Strive Asset Management is another remarkable addition to my portfolio of companies. Founded in 2022, Strive Asset Management is an investment firm that sets itself apart by prioritizing the needs of its customers above all else. As an “anti-woke” index fund provider, we focus on delivering excellent products and services without any political or social agendas.

Backed by notable investors like Peter Thiel and Bill Ackman, Strive Asset Management has quickly gained recognition in the finance industry. With a valuation of around $300 million, our firm is committed to delivering exceptional results for our clients. Our investment strategies are meticulously crafted to ensure maximum returns and long-term growth.

At Strive Asset Management, we believe in the power of transparency and trust. We aim to build strong relationships with our clients, providing them with comprehensive insights and guidance for their investment journey. Our team of experienced professionals is dedicated to delivering personalized solutions tailored to each client’s unique financial goals.

As part of my commitment to building successful ventures across various sectors, Strive Asset Management showcases my business acumen and the ability to identify opportunities for growth. With a diverse portfolio of Vivek Ramaswamy-owned companies, including Roivant Sciences and Strive Asset Management, I continue to make strategic investments that contribute to the expansion and success of my businesses.